awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26751280-D19C6BBF-DB89-41B5-9A0F-753EF8FA63CC
Q26751280-D19C6BBF-DB89-41B5-9A0F-753EF8FA63CC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26751280-D19C6BBF-DB89-41B5-9A0F-753EF8FA63CC
Profile of bevacizumab in the treatment of platinum-resistant ovarian cancer: current perspectives
P2860
Q26751280-D19C6BBF-DB89-41B5-9A0F-753EF8FA63CC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26751280-D19C6BBF-DB89-41B5-9A0F-753EF8FA63CC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
30c8f9cfdb31c85f2c19faff9063312def4b310e
P2860
Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial.